Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
Journal of Neurochemistry|April 1, 1995
The third intracellular loop of the 5-hydroxytryptamine2A receptor determines effector coupling specificityD Oksenberg, S Havlik, S J Peroutka, et al.Life Sciences|January 1, 1990
6-substituted tricyclic partial ergoline compounds are selective and potent 5-hydroxytryptamine1A receptor agentsJ L Slaughter, M A Harrington, S J PeroutkaPsychopharmacology|January 1, 1988
R(-)-2,5-dimethoxy-4-77 bromoamphetamine [77Br-R(-)DOB]: a novel radioligand which labels a 5-HT binding site subtypeS S Wang, C A Mathis, S J PeroutkaLife Sciences|January 1, 1991
5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agentS J Peroutka, B G McCarthy, X M GuanJournal of Neurology, Neurosurgery, and Psychiatry|April 1, 1985
Calcium channel antagonism by pizotifenS J Peroutka, S B Banghart, G S AllenNeurology|June 1, 1987
Treatment of lethal pertussis vaccine reaction with histamine H1 antagonistsS J Peroutka, K Kitamura, M Lim, et al.Annals of Neurology|May 1, 1986
Antimigraine drug interactions with 5-hydroxytryptamine1A receptorsB C Hiner, H L Roth, S J PeroutkaNeuroscience Letters|September 25, 1989
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the ratC R Hekmatpanah, D J McKenna, S J PeroutkaEuropean Journal of Pharmacology|June 26, 1987
[3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paperS S Wang, G A Ricaurte, S J PeroutkaBritish Journal of Pharmacology|June 1, 1991
Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura materM G Buzzi, M A Moskowitz, S J Peroutka, et al.Pageof 15